Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari.

Translated title of the contribution: Advantages of a permanent venous access in children treated for cancer. Preliminary results

A. Garaventa, A. Rizzo, G. Ivani, R. Vallarino, A. Taccone, C. Viscoli, G. Perlino, B. De Bernardi

Research output: Contribution to journalArticle

Abstract

Current therapy for children with cancer includes a variety of invasive procedures many of which require repeated venous access over a considerable period of time. Such procedures are poorly tolerated by children and by their veins. Recently it has become possible to undertake the majority of such procedures by means of permanent indwelling silastic catheters improving the quality of life of the children and their parents and increasing the scope of therapeutic intervention. In the period July '83 - August '84 we have used 46 of these catheters in 45 children with malignant disease, 12 with acute myeloid leukaemia, 12 with neuroblastoma, 7 with B cell leukaemia-lymphoma, 6 with rhabdomyosarcomas, 2 with Ewing's Sarcoma, 2 with Wilms' tumor and 1 case each of Hodgkin's disease, teratocarcinoma, osteosarcoma and juvenile chronic myeloid leukaemia. The children's ages ranged from 2 months to 14 years; 22 were male and 23 female. The catheters were inserted under general anaesthesia (duration 20-40 minutes) usually without difficulty, except for a single patient in whom no suitable vein could be found. No complications connected with the placement of the catheter were observed. Subsequent management of the catheter was initially complicated and time-consuming, but was subsequently simplified so that acceptance by parents, children and nursing staff was eventually excellent. The duration of use of 46 catheters ranges from 7 to 350+ days; 24 catheters are presently in use at 30-350+ days from insertion. Eight children died as a result of disease progression and two of sepsis with the catheter in place.(ABSTRACT TRUNCATED AT 250 WORDS)

Original languageItalian
Pages (from-to)717-721
Number of pages5
JournalPediatria Medica e Chirurgica
Volume7
Issue number5
Publication statusPublished - Sep 1985

Fingerprint

Catheters
Neoplasms
Veins
Parents
B-Cell Leukemia
Teratocarcinoma
Ewing's Sarcoma
Indwelling Catheters
Wilms Tumor
Rhabdomyosarcoma
Nursing Staff
B-Cell Lymphoma
Osteosarcoma
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hodgkin Disease
Neuroblastoma
Acute Myeloid Leukemia
General Anesthesia
Disease Progression
Sepsis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari. / Garaventa, A.; Rizzo, A.; Ivani, G.; Vallarino, R.; Taccone, A.; Viscoli, C.; Perlino, G.; De Bernardi, B.

In: Pediatria Medica e Chirurgica, Vol. 7, No. 5, 09.1985, p. 717-721.

Research output: Contribution to journalArticle

Garaventa, A, Rizzo, A, Ivani, G, Vallarino, R, Taccone, A, Viscoli, C, Perlino, G & De Bernardi, B 1985, 'Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari.', Pediatria Medica e Chirurgica, vol. 7, no. 5, pp. 717-721.
Garaventa, A. ; Rizzo, A. ; Ivani, G. ; Vallarino, R. ; Taccone, A. ; Viscoli, C. ; Perlino, G. ; De Bernardi, B. / Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari. In: Pediatria Medica e Chirurgica. 1985 ; Vol. 7, No. 5. pp. 717-721.
@article{46f653c280a6439aa279154e642116e0,
title = "Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari.",
abstract = "Current therapy for children with cancer includes a variety of invasive procedures many of which require repeated venous access over a considerable period of time. Such procedures are poorly tolerated by children and by their veins. Recently it has become possible to undertake the majority of such procedures by means of permanent indwelling silastic catheters improving the quality of life of the children and their parents and increasing the scope of therapeutic intervention. In the period July '83 - August '84 we have used 46 of these catheters in 45 children with malignant disease, 12 with acute myeloid leukaemia, 12 with neuroblastoma, 7 with B cell leukaemia-lymphoma, 6 with rhabdomyosarcomas, 2 with Ewing's Sarcoma, 2 with Wilms' tumor and 1 case each of Hodgkin's disease, teratocarcinoma, osteosarcoma and juvenile chronic myeloid leukaemia. The children's ages ranged from 2 months to 14 years; 22 were male and 23 female. The catheters were inserted under general anaesthesia (duration 20-40 minutes) usually without difficulty, except for a single patient in whom no suitable vein could be found. No complications connected with the placement of the catheter were observed. Subsequent management of the catheter was initially complicated and time-consuming, but was subsequently simplified so that acceptance by parents, children and nursing staff was eventually excellent. The duration of use of 46 catheters ranges from 7 to 350+ days; 24 catheters are presently in use at 30-350+ days from insertion. Eight children died as a result of disease progression and two of sepsis with the catheter in place.(ABSTRACT TRUNCATED AT 250 WORDS)",
author = "A. Garaventa and A. Rizzo and G. Ivani and R. Vallarino and A. Taccone and C. Viscoli and G. Perlino and {De Bernardi}, B.",
year = "1985",
month = "9",
language = "Italian",
volume = "7",
pages = "717--721",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "5",

}

TY - JOUR

T1 - Vantaggi di un accesso venoso permanente in bambini trattati per malattie oncologiche. Risultati preliminari.

AU - Garaventa, A.

AU - Rizzo, A.

AU - Ivani, G.

AU - Vallarino, R.

AU - Taccone, A.

AU - Viscoli, C.

AU - Perlino, G.

AU - De Bernardi, B.

PY - 1985/9

Y1 - 1985/9

N2 - Current therapy for children with cancer includes a variety of invasive procedures many of which require repeated venous access over a considerable period of time. Such procedures are poorly tolerated by children and by their veins. Recently it has become possible to undertake the majority of such procedures by means of permanent indwelling silastic catheters improving the quality of life of the children and their parents and increasing the scope of therapeutic intervention. In the period July '83 - August '84 we have used 46 of these catheters in 45 children with malignant disease, 12 with acute myeloid leukaemia, 12 with neuroblastoma, 7 with B cell leukaemia-lymphoma, 6 with rhabdomyosarcomas, 2 with Ewing's Sarcoma, 2 with Wilms' tumor and 1 case each of Hodgkin's disease, teratocarcinoma, osteosarcoma and juvenile chronic myeloid leukaemia. The children's ages ranged from 2 months to 14 years; 22 were male and 23 female. The catheters were inserted under general anaesthesia (duration 20-40 minutes) usually without difficulty, except for a single patient in whom no suitable vein could be found. No complications connected with the placement of the catheter were observed. Subsequent management of the catheter was initially complicated and time-consuming, but was subsequently simplified so that acceptance by parents, children and nursing staff was eventually excellent. The duration of use of 46 catheters ranges from 7 to 350+ days; 24 catheters are presently in use at 30-350+ days from insertion. Eight children died as a result of disease progression and two of sepsis with the catheter in place.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - Current therapy for children with cancer includes a variety of invasive procedures many of which require repeated venous access over a considerable period of time. Such procedures are poorly tolerated by children and by their veins. Recently it has become possible to undertake the majority of such procedures by means of permanent indwelling silastic catheters improving the quality of life of the children and their parents and increasing the scope of therapeutic intervention. In the period July '83 - August '84 we have used 46 of these catheters in 45 children with malignant disease, 12 with acute myeloid leukaemia, 12 with neuroblastoma, 7 with B cell leukaemia-lymphoma, 6 with rhabdomyosarcomas, 2 with Ewing's Sarcoma, 2 with Wilms' tumor and 1 case each of Hodgkin's disease, teratocarcinoma, osteosarcoma and juvenile chronic myeloid leukaemia. The children's ages ranged from 2 months to 14 years; 22 were male and 23 female. The catheters were inserted under general anaesthesia (duration 20-40 minutes) usually without difficulty, except for a single patient in whom no suitable vein could be found. No complications connected with the placement of the catheter were observed. Subsequent management of the catheter was initially complicated and time-consuming, but was subsequently simplified so that acceptance by parents, children and nursing staff was eventually excellent. The duration of use of 46 catheters ranges from 7 to 350+ days; 24 catheters are presently in use at 30-350+ days from insertion. Eight children died as a result of disease progression and two of sepsis with the catheter in place.(ABSTRACT TRUNCATED AT 250 WORDS)

UR - http://www.scopus.com/inward/record.url?scp=0022114664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022114664&partnerID=8YFLogxK

M3 - Articolo

C2 - 3837238

AN - SCOPUS:0022114664

VL - 7

SP - 717

EP - 721

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 5

ER -